Charles Schwab’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.1K Sell
18,201
-9,140
-33% -$38.1K ﹤0.01% 3405
2025
Q4
$118K Buy
27,341
+13,074
+92% +$49.9K ﹤0.01% 3389
2025
Q3
$61.9K Hold
14,267
﹤0.01% 3416
2025
Q2
$66.2K Buy
+14,267
New +$56.4K ﹤0.01% 3436

Other funds holding SBC

Charles Schwab's SBC Position: Q1 2026 in Review

Charles Schwab reduced its SBC Medical Group (SBC) stake by 33% in Q1 2026, selling an estimated $38.1K and leaving 18,201 shares worth $76.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3405.

Charles Schwab first reported a position in SBC in Q2 2025 and has held it in 4 quarters since. The position peaked at $118K in Q4 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Charles Schwab held 18,201 shares of SBC Medical Group worth $76.1K as of Q1 2026.
  • Charles Schwab sold 9,140 SBC Medical Group shares in Q1 2026, an estimated $38.1K.
  • SBC Medical Group made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #3405 holding.
  • Charles Schwab first reported a position in SBC Medical Group in Q2 2025 and has held it in 4 quarters since.
  • Charles Schwab's SBC Medical Group position peaked at $118K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.